Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet.

Free Radical Biology & Medicine
Jaya R P PrasanthiOthman Ghribi

Abstract

Cholesterol has been linked to the pathogenesis of sporadic Alzheimer's disease (AD) as a risk factor increasing beta-amyloid (Abeta) and oxidative stress levels. Caffeine has antioxidant properties and has been demonstrated to reduce Abeta levels in transgenic mouse models of familial AD. However, the effects of caffeine on cholesterol-induced sporadic AD pathology have not been determined. In this study, we determined the effects of caffeine on Abeta levels, tau phosphorylation, oxidative stress generation, and caffeine-target receptors in rabbits fed a 2% cholesterol-enriched diet, a model system for sporadic AD. Our results showed that the cholesterol-enriched diet increased levels of Abeta, tau phosphorylation, and oxidative stress measured as increased levels of reactive oxygen species and isoprostanes, glutathione depletion, and increased levels of endoplasmic reticulum stress marker proteins. Additionally, the cholesterol-enriched diet reduced the levels of adenosine A(1) receptors (A(1)R) but not ryanodine or adenosine A(2A) receptors. Caffeine, administered at 0.5 and 30mg/day in the drinking water, reduced the cholesterol-induced increase in Abeta, phosphorylated tau, and oxidative stress levels and reversed the chol...Continue Reading

Citations

Apr 13, 2013·Journal of Agricultural and Food Chemistry·Alessia PanusaRita Petrucci
May 9, 2012·International Journal of Alzheimer's Disease·Bernard G SchreursJimena Gonzalez-Joekes
Feb 14, 2014·The Journal of Nutrition, Health & Aging·A Gramza-Michałowska
Aug 14, 2012·Oxidative Medicine and Cellular Longevity·Ye Feng, Xiaochuan Wang
Nov 22, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ningjian Liang, David D Kitts
Feb 24, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Karolina A Wojtunik-KuleszaMonika Waksmundzka-Hajnos
Dec 31, 2015·Asian Journal of Sports Medicine·Akbar ZeraatpisheHamid Reza Espanani
Aug 2, 2015·Neurochemistry International·Rajib PaulAnupom Borah
Jul 30, 2015·Neurochemistry International·Yu Pong NgNancy Y Ip
Mar 15, 2013·Neurochemistry International·Mauren Assis SouzaLuiz Fernando Freire Royes
Mar 22, 2014·Biochemical Society Transactions·Vanessa FlatenDavid Blum
Nov 29, 2011·Experimental Neurology·Gurdeep Marwarha, Othman Ghribi
Oct 17, 2013·Free Radical Biology & Medicine·Stefanie EndesfelderThomas Schmitz
Jun 23, 2011·Pharmacology, Biochemistry, and Behavior·Renata Viana AbreuTasso Moraes-Santos
Apr 26, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rosaliana LibroEmanuela Mazzon
Mar 29, 2011·The Journal of Physical Chemistry. B·Jorge Rafael León-Carmona, Annia Galano
Oct 30, 2016·Journal of Alzheimer's Disease : JAD·Jesus Mendiola-PrecomaGuadalupe García-Alcocer
Mar 21, 2017·CNS Neuroscience & Therapeutics·Mahshad Kolahdouzan, Mazen J Hamadeh
Jan 21, 2017·International Journal of Molecular Sciences·Stefanie EndesfelderThomas Schmitz
Apr 7, 2018·Critical Reviews in Food Science and Nutrition·João MonteiroBranca M Silva
Jan 8, 2019·Critical Reviews in Food Science and Nutrition·Muhammad SaeedSun Chao
Jul 23, 2019·Medicinal Research Reviews·Lili ZhangRongbiao Pi
Apr 27, 2019·Archives of Microbiology·Clara A Quiñones-GonzálezEduardo Campos-Góngora
Jun 24, 2017·Neurotoxicity Research·Stefanie EndesfelderChristoph Bührer
Mar 9, 2018·Nutritional Neuroscience·Eman N HosnyYasser A Khadrawy
Jun 4, 2020·Antioxidants & Redox Signaling·Germán Plascencia-Villa, George Perry
Jun 5, 2017·Metabolic Brain Disease·Seyed Soheil Saeedi SaraviAhmad Reza Dehpour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.